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A Novel Magnetic Resonance Imaging Score Predicts
Neurodevelopmental Outcome After Perinatal Asphyxia and
Therapeutic Hypothermia
Lauren C. Weeke, MD, PhD1, Floris Groenendaal, MD, PhD1, Kalyani Mudigonda, MD2, Mats Blennow, MD, PhD2,
Maarten H. Lequin, MD, PhD3, Linda C. Meiners, MD, PhD4, Ingrid C. van Haastert, MA, PhD1, Manon J. Benders, MD, PhD1,
Boubou Hallberg, MD, PhD2,*, and Linda S. de Vries, MD, PhD1,*
Objective To assess the predictive value of a novel magnetic resonance imaging (MRI) score, which includes
diffusion-weighted imaging as well as assessment of the deep grey matter, white matter, and cerebellum, for
neurodevelopmental outcome at 2 years and school age among term infants with hypoxic-ischemic encephalopa-
thy treated with therapeutic hypothermia.
Study design This retrospective cohort study (cohort 1, The Netherlands 2008-2014; cohort 2, Sweden 2007-
2012) including infants born at >36 weeks of gestational age treated with therapeutic hypothermia who had an MRI
in the first weeks of life. The MRI score consisted of 3 subscores: deep grey matter, white matter/cortex, and cer-
ebellum. Primary adverse outcome was defined as death, cerebral palsy, Bayley Scales of Infant and Toddler De-
velopment, third edition, motor or cognitive composite scores at 2 years of <85, or IQ at school age of <85.
Results In cohort 1 (n = 97) and cohort 2 (n = 76) the grey matter subscore was an independent predictor of adverse
outcome at 2 years (cohort 1, OR, 1.6; 95% CI, 1.3-1.9; cohort 2, OR, 1.4; 95% CI, 1.2-1.6), and school age (cohort
1, OR, 1.3; 95% CI, 1.2-1.5; cohort 2, OR, 1.3; 95% CI, 1.1-1.6). The white matter and cerebellum subscore did
not add to the predictive value. The positive predictive value, negative predictive value, and area under the curve
for the grey matter subscore were all >0.83 in both cohorts, whereas the specificity was >0.91 with variable sensitivity.
Conclusion A novel MRI score, which includes diffusion-weighted imaging and assesses all brain areas of
importance in infants with therapeutic hypothermia after perinatal asphyxia, has predictive value for outcome
at 2 years of age and at school age, for which the grey matter subscore can be used independently.
(J Pediatr 2018;192:33-40).
A lthough therapeutic hypothermia after perinatal asphyxia has reduced the incidence of adverse outcome, 45% of infantsstill die or have neurodevelopmental impairment.1-7 Magnetic resonance imaging (MRI) and proton magnetic reso-nance spectroscopy (1H-MRS) have been shown to be excellent predictors of outcome4,8-11 and are often used as bridg-
ing biomarkers for neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy (HIE).12,13 Quantifying the
extent of brain injury in these infants is important for objective and accurate prognostication and guiding decisions on redi-
rection of care. Many existing MRI scores do not include diffusion-weighted images (DWI),4,9,10,14 even though DWI has been
shown to be the most reliable MRI sequence to assess injury during the first week after an hypoxic-ischemic event.15 Early de-
tection is important for the selection of future additional neuroprotective strategies, which may need to be initiated within the
first week after birth. Some abnormalities encountered on MRIs of infants with HIE, such as intracranial hemorrhages, cer-
ebellar lesions, and MRS abnormalities are not part of existing scores, although
they may be of additional value. We developed a novel score based on assess-
ment of all MRI abnormalities of suspected importance for prognostication in
infants with HIE.We hypothesized that our novel MRI score, which includes DWI
as well as assessment of the deep grey matter, white matter, and cerebellum, will
1H-MRS Proton magnetic resonance spectroscopy
ADC Apparent diffusion coefficient
BSITD-III Bayley Scales of Infant and Toddler Development, third edition
CP Cerebral palsy
DWI Diffusion-weighted image
GMFCS Gross Motor Function Classification System
HIE Hypoxic-ischemic encephalopathy
MRI Magnetic resonance imaging
NAA N-acetyl aspartate
WISC-IV-SV Wechsler Intelligence Scale for Children, fourth edition, Swedish version
WPPSI-III-NL Wechsler Preschool and Primary Scale of Intelligence, third edition, Dutch version
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have a better predictive value for neurodevelopmental outcome
at 2 years of age and at school age than conventional MRI-
based scoring systems that have been described previously.
Methods
The ethics committees of both participating centers waived the
requirement to obtain informed consent for this retrospec-
tive study with anonymized data. Infants born after a gesta-
tional age of >36 weeks admitted to a level III neonatal intensive
care unit in the Netherlands (cohort 1, January 2008-March
2014; n = 97) and Sweden (cohort 2, January 2007–December
2009; n = 76) treated with therapeutic hypothermia for HIE
(defined as a Thompson score of >7 and/or a discontinuous
electroencephalograph) owing to presumed perinatal as-
phyxia (5-minute Apgar score ≤5, pH ≤7.10, base deficit
≥16 mmol/L, or resuscitation 10 minutes after birth) and ex-
amined by brain MRI as part of routine clinical care were in-
cluded. Infants with major congenital abnormalities, inborn
errors of metabolism, and genetic syndromes were excluded.
In both centers whole-body cooling was started as soon as pos-
sible within 6 hours after birth and continued for 72 hours.
After 72 hours, the babies were rewarmed gradually to 36.5°C.
After rewarming, the babies were kept at a temperature of
36.5°C for 12-24 hours.
In both cohorts, MRI was performed on a 1.5-T or 3.0-T
magnet (Philips Medical Systems, Best, The Netherlands, GE
Healthcare, Chicago, Illinois), within the first weeks after birth.
Standard MRI protocol included axial T1-weighted images or
inversion recovery-weighted images, T2-weighted images, DWI
including apparent diffusion coefficient (ADC) mapping. Only
in cohort 1 were 1H-MRS measurements in the basal ganglia
and thalamus performed (details published previously).8
The MRI score was designed based on previously pub-
lished scores and the patterns of brain injury reported in the
literature (Table I; available at www.jpeds.com).10,13,14 Our score
assesses brain injury in 3 areas: (1) deep grey matter (items
scored: thalamus, basal ganglia, posterior limb of the inter-
nal capsule, brainstem, perirolandic cortex, and hippocam-
pus; maximum grey matter subscore, 23), (2) cerebral white
matter/cortex (items scored: cortex, cerebral white matter, optic
radiations, corpus callosum, punctate white matter lesions, and
parenchymal hemorrhage; maximum white matter subscore,
21), and (3) cerebellum (items scored: cerebellum and cer-
ebellar hemorrhage; maximum cerebellum subscore, 8). Each
item was scored for extent of injury: 0 (no injury), 1 (focal,
<50%), or 2 (extensive, ≥50%) and for unilateral (score of 1)
or bilateral (score of 2) presence, the items were not weighted
at this stage. A fourth group (additional) was included, as-
sessing the presence of intraventricular or subdural hemor-
rhages and sinovenous thrombosis 0 if absent, 1 if present. The
maximum additional subscore was 3. The total score was cal-
culated by adding the 4 subscores (grey matter + white matter
+ cerebellum + additional; maximum score, 55). In cases where
1H-MRS was performed in the basal ganglia and thalamus,
N-acetyl aspartate (NAA) and lactate were scored 0 (normal
NAA peak, absent lactate peak) or 1 (reduced NAA peak, in-
creased lactate peak), which was subsequently included in the
grey matter subscore (maximum grey matter subscore, 24; total
score, 57). TheADCmeasurements were performed when visual
analysis of the ADC map was inconclusive, and items were
scored as abnormal if the ADC values in the specific area were
lower than previously defined cutoff values.8 MRI examples
for each item of the score are shown in Figure 1.
Two reviewers blinded to patient outcomes assessed all MRIs
using the score described above. In case of disagreement con-
sensus was obtained with a third blinded reviewer. To deter-
mine inter-rater reliability, 2 additional blinded pediatric
radiologists (one local to Utrecht one external to the institu-
tions scored the injury on MRI on a subset of scans (n = 10).
Neurodevelopmental Outcome
The Bayley Scales of Infant and Toddler Development, third
edition (BSITD-III), was used to assess outcome at 2 years.16
TheWechsler Preschool and Primary Scale of Intelligence, third
edition, Dutch version (WPPSI-III-NL)17 andWechsler Intel-
ligence Scale for Children, fourth edition, Swedish version
(WISC-IV-SE)18 was used to assess IQ at school age (cohort
1, 5.5-6.5 years; cohort 2, 6.5-8 years). Severity of cerebral palsy
(CP) was classified according to the GrossMotor Function Clas-
sification System (GMFCS).19 For infants with CP who could
not be tested with the BSITD-III, a motor composite score was
assigned, 70 (-2 SD on the BSITD-III) for GMFCS III, and 45
(-3 SD) for GMFCS IV-V. For infants with severe CP (GMFCS
V) who could not be tested with the BSITD-III, a cognitive
composite score and for the WPPSI-III-NL or WISC-IV-SE a
total IQ score of 45 was assigned. Abnormal outcome was
defined at 2 years as death, CP (GMFCS ≥ II), or a BSITD score
<85 (-1 SD) for motor or cognitive composite score, and at
school age as death, CP (GMFCS ≥ II) or an IQ <85.
Statistical Analyses
GraphPad Prism 6 (GraphPad Software Inc, La Jolla, Califor-
nia) was used to generate receiver operating characteristic
curves, calculate the area under the curve, and determine the
cutoff values for the MRI score (total and subscores) based on
the point on the receiver operating characteristic curve closest
to the (0,1) point.
Cronbach alpha was used to determine the intraclass cor-
relation coefficient, as a measure of inter-rater reliability for
the total score and all subscores. Sensitivity, specificity, posi-
tive predictive value, negative predictive value, and accuracy
(total number of correctly predicted individuals [true posi-
tive + true negative/all observations × 100]) were calculated.
SPSS 21 (IBM Corp, Armonk, New York) was used to deter-
mine differences between the 2 cohorts in baseline character-
istics using the MannWhitney U test and the c2 or Fisher exact
test and to perform univariate and multivariable logistic re-
gression to investigate the association between adverse outcome,
the BSITD-III and IQ scores, and the MRI subscores. BSITD-
III and IQ scores were dichotomized for logistic regression, with
85 (−1 SD) being the cutoff level for adverse outcome. P < .05
was considered significant.
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Figure 1. MRI examples of all items to be scored with the novel MRI score. The abnormalities of interest are marked by the
white arrows. A, Focal bilateral thalamic lesions (high signal intensity [SI]) on an axial DWI. B, Extensive bilateral thalamic lesions
(low SI) on an axial ADC map. C, Focal bilateral lesions (high SI) in the basal ganglia on an axial DWI. D, Extensive bilateral
lesions (high SI) in the basal ganglia on an axial DWI. E, The posterior limb of the internal capsule (PLIC) is equivocal on both
sides on an axial inversion recovery (IR) image. F, Absent PLIC bilaterally seen as an inverted signal (low SI) on an axial T1-
weighted image (T1WI). G, Focal lesion (high SI) in the left cerebral peduncle on an axial DWI. H, Extensive diffusion changes
(high SI) in the cerebral peduncles bilaterally on an axial DWI. I, Clear involvement (high SI) of the perirolandic gyrus bilaterally
on an axial DWI. J, Bilateral involvement (low SI) of the hippocampus on an axial ADC map. K, Focal involvement (high SI) of
the left cortex on an axial DWI. L, Extensive bilateral involvement of the cortex, seen as loss of the differentiation between the
white matter and cortical grey matter in the occipital and frontal lobes bilaterally. M, Focal unilateral abnormal signal (low SI) in
the left periventricular white matter on an axial ADC map. N, Extensive involvement of the white matter (high SI) on an axial
DWI. O, Bilateral punctate white matter lesions (PWML) seen as high SI on an axial DWI. P, A small focal hemorrhage in the
right occipital lobe (low SI) on an axial T2-weighted image (T2WI). Q, Bilateral involvement of the optic radiation (high SI) on
an axial DWI. R, Involvement of the frontal part of the corpus callosum (high SI) on an axial DWI. S, Focal lesion (high SI) in
the left cerebellar hemisphere on an axial T1WI. T, Extensive involvement of both cerebellar hemispheres (high SI) on an axial
DWI. U, Bilateral intraventricular hemorrhage (IVH) seen as low SI on an axial T2WI. V, Subdural hemorrhage (SDH) supra-
and infratentorial seen as high SI on a sagittal T1WI. W, Cerebral sinovenous thrombosis (CSVT) seen as high SI at the loca-
tion of the superior sagittal and straight sinus on a sagittal T1WI. X, With corresponding lack flow (lack of high SI) in those
veins on an MR venography (MRV) in sagittal view.
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Results
MRI scans from cohort 1 were used to develop the score and
scans from cohort 2 to validate it. In cohort 1, there were 27
infants with a normal scan and in cohort 2, there were 16
infants. The majority of scans were obtained in the first week
after birth (81%). The quality of the scans was good (no move-
ment artefacts, high resolution) in 85.6% for cohort 1 and
71.4% for cohort 2. The baseline characteristics are shown in
Table II. Cohort 2 had a higher gestational age at birth, higher
birth weights, lower Apgar scores at 5minutes, and fewer deaths,
but a higher survival rate with impairment at 2 years of age
compared with cohort 1. One infant with CP had a GMFCS
II (cohort 1), and the other infants with CP had a GMFCS ≥ III
(all cohort 2); the GMFCS level did not change between 2 years
of age and school age.
Cronbach alpha was 0.95 for the total score without 1H-
MRS (0.96 including 1H-MRS), 0.98 for the grey matter
subscore with and without 1H-MRS, 0.94 for the white matter
subscore, 0.72 for the cerebellum subscore, and 0.89 for the
additional subscore.
MRI Score and Neurodevelopmental Outcome
At 2 years of age, outcome data were available for all infants in
both cohorts. The grey matter, white matter, and cerebellum
subscores were significantly associated with death or adverse
outcome in both cohorts and were subsequently included in
a multivariable analysis. The multivariable regression model
included grey matter subscore as an independent predictor of
death or impairment at 2 years of age in cohort 1 (modelwithout
1H-MRS: OR, 1.6, 95% CI, 1.3-1.9 [ß0 = −4.579, ß1 = 0.456];
model with 1H-MRS: OR, 1.6, 95% CI, 1.3-1.9 [ß0 = −5.017,
ß1= 0.443]) and cohort 2 (model without 1H-MRS: OR 1.4,
95% CI 1.2-1.6 [ß0 = −2.310, ß1 = 0.322]).
At school age (cohort 1, mean of 5.9 years; cohort 2, mean
of 7.5 years), outcome data were available for 53 infants in
cohort 1: 22 died and 31 had follow-up assessment. For 44
infants, no follow-up information was available at school age:
35 were too young, 1 was not testable owing to behavioral prob-
lems, and 8 were not tested for unknown reasons. In cohort
2, outcome data at school age were available for 46 infants: 5
died and 41 had follow-up assessment. For 30 infants, no follow-
up information at school age was available: 19 were too young
and 11 were not tested for unknown reasons. There were no
differences in baseline characteristics between infants with
follow-up assessment and those lost to follow-up. The grey
matter and white matter subscores were significantly associ-
ated with death or adverse outcome in both cohorts. The grey
matter, white matter, and cerebellum subscores were in-
cluded in a multivariable analysis. The multivariable regres-
sionmodel included the greymatter subscore as an independent
predictor of death or impairment at school age in both cohort
1 (model without 1H-MRS: OR, 1.3, 95% CI, 1.2-1.5
[ß0 = −2.394, ß1 = 0.292], model with 1H-MRS: OR, 1.3, 95%
CI, 1.1-1.5 [ß0 = −2.333, ß1 = 0.262]) and cohort 2 (model
Table II. Baseline characteristics of the 2 cohorts
Cohort 1 n = 97 Cohort 2 n = 76 P value
Gestational age (wk), mean (SD) 39.9 (1.6) 40.3 (1.4) .060
Birth weight (g), mean (SD) 3497 (610) 3708 (662) .039
Male, n (%) 53 (54.6) 36 (47.4) 0.342
Apgar at 5 min, median (IQR) 4 (2-5) 3 (2-4) .032
Sarnat grade, n (%)* .056
1 12 (12.4) 4 (5.3)
2 67 (69.1) 62 (81.6)
3 18 (18.6) 7 (9.2)
MRI
MRI age (day of life), median (IQR) 6 (5-7) 6 (5-8) 0.315
Total score, median (IQR) 6 (0-22) 3 (1-11.8) 0.122
Grey matter subscore 0 (0-11.5) 0 (0-4.5)
White matter subscore 4 (0-8) 2 (0-7)
Cerebellum subscore 0 (0-4) 0 (0-0)
Outcome
Died, n (%) 22 (22.7) 5 (6.6) .004
Age at BSITD-III assessment in months, mean (SD) 24.13 (0.42) 25.92 (1.68) <.001
BSITD-III motor composite score, mean (SD) 112 (12) 95 (23)† <.001
BSITD-III cognitive composite score, mean (SD) 107 (14) 95 (21) <.001
Age at IQ assessment in years, mean (SD) 5.9 (0.3) 7.5 (0.8) <.001
IQ, mean (SD) 102 (17)‡ 100 (19)§ 0.555
Impairment at 2 years, n (%) 4 (4.1) 14 (18.4) .029
BSITD-III motor composite score < 85 2 (2.1) 13 (17.1)
BSITD-III cognitive composite score < 85 2 (2.1) 10 (13.2) 0.773
Impairment at school age, n (%) 4 (7.5)† 5 (10.9)§
CP 1 (1.9) 4 (8.7)
IQ < 85 3 (5.7) 4 (8.7)
*Data available for 73 subjects in cohort 2.
†Data available for 57 subjects.
‡Data available for 53 subjects.
§Data available for 46 subjects.
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without 1H-MRS: OR, 1.3, 95% CI, 1.1-1.6 [ß0 = −2.747,
ß1 = 0.286]).
The grey matter subscore was significantly correlated with
the white matter and cerebellum subscore in both cohorts
(P < .001). Entering white matter and/or cerebellum subscores
in the models resulted in a reduction in the OR of the grey
matter subscore, suggesting multicollinearity.
Receiver operating characteristic curves for adverse outcome
at 2 years of age and at school age were plotted for the grey
matter subscore because injury to the grey matter subscore was
an independent predictor of outcome. The area under the curve
values with 95%CIs and sensitivity and specificity for the cutoff
values are shown in Table III. Figure 2 shows the distribu-
tion of the individual scores in all infants with a normal vs an
Table III. Cross-tabulation of the MRI score results*
Score
Diagnostic accuracy
Cutoff Normal Abnormal AUC (95% CI) Sensitivity Specificity PPV NPV Accuracy
Cohort 1
Outcome at 2 y
Grey matter without 1H-MRS <9.50 68 2 0.988 (0.973-1.000) 0.923 0.958 0.889 0.971 0.948
Grey matter without 1H-MRS ≥9.50 3 24
Grey matter including 1H-MRS <11.50 61 2 0.989 (0.973-1.000) 0.923 0.953 0.889 0.968 0.944
Grey matter including 1H-MRS ≥11.50 3 24
Outcome at school age
Grey matter without 1H-MRS <11.50 25 4 0.945 (0.878-1.000) 0.846 0.926 0.917 0.862 0.887
Grey matter without 1H-MRS ≥11.50 2 22
Grey matter including 1H-MRS <12.50 20 3 0.935 (0.855-1.000) 0.885 0.909 0.920 0.870 0.896
Grey matter including 1H-MRS ≥12.50 2 23
Cohort 2
Outcome at 2 y
Grey matter without 1H-MRS <9.50 56 11 0.832 (0.708-0.955) 0.421 0.982 0.889 0.836 0.842
Grey matter without 1H-MRS ≥9.50 1 8
Outcome at school age
Grey matter without 1H-MRS <11.50 36 5 0.861 (0.726-0.997) 0.500 1.000 1.000 0.878 0.891
Grey matter without 1H-MRS ≥11.50 0 5
AUC, Area under the curve; NPV, negative predictive value; PPV, positive predictive value.
*Based on the optimal cutoff values for the grey matter subscore.
Figure 2. Individual score values on the grey matter subscore for infants with a normal (open circles) and infants with an ab-
normal outcome (death, black crosses; CP, black squares; other impairment, open squares) A, B, at 2 years of age; and C, D,
at school age; A, C, in cohort 1; and B, D, cohort 2. The black horizontal lines indicate the median. The dotted horizontal lines
indicate the cutoff values for risk of adverse outcome.
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abnormal outcome at 2 years of age and at school age in both
cohorts. A predicted probability graph for adverse outcome at
2 years of age and at school age was generated for the grey
matter subscore in cohort 1 (Figure 3; available at
www.jpeds.com).
Adverse Outcome at 2Years of Age and at School Age in Sur-
viving Infants. The relationship between the MRI scores and
the BSITD-III motor and cognitive composite scores at 2 years
or the IQ at school age was assessed on the pooled cohort
(cohorts 1 + 2), because the number of surviving infants with
impairment was too small in the separate cohorts. At 2 years
of age, the BSITD-III motor composite score was not avail-
able for 14 infants and a motor composite score was assigned
for 5 infants with CP in cohort 2. At school age, an IQ score
was assigned for 3 infants with CP in cohort 2. The grey matter
and white matter subscores were significantly associated with
a motor or cognitive composite score of <85 at 2 years of age.
None of the subscores was significantly associated with an IQ
<85 at school age. The multivariable logistic regression model
included the grey matter subscore as an independent predic-
tor of motor (model without 1H-MRS: OR, 1.3, 95% CI, 1.2-
1.5 [ß0 = −3.126, ß1 = 0.294]) and cognitive impairment (model
without 1H-MRS: OR, 1.3, 95% CI, 1.2-1.5 [ß0 = −3.504,
ß1 = 0.290]) at 2 years of age. No analyses were performed on
the scores, including 1H-MRS results, because these were only
available for cohort 1.
Discussion
We developed an easily applicable, comprehensive MRI score
that showed good predictive value in 2 independent, interna-
tional cohorts, comprising a total of 173 infants treated with
therapeutic hypothermia. In both cohorts, injury to the deep
grey matter area was an independent predictor of adverse
outcome at 2 years of age and at school age. The grey matter
subscore may be useful for outcome prediction in hypothermia-
treated infants with HIE. The presented cutoff values and pre-
dicted probability graphs could be used to aid clinical decision-
making or as an outcome measure in clinical trials. The inter-
rater reliability was high and the predictive value remained good
in cohort 2.
Most previously published MRI scoring systems that have
been related to outcome9,10,14 were designed to be performed
using T1- andT2-weighted images only and therefore use scans
obtained in the second week of life, because abnormalities on
these sequences may not yet be present in the first week.20 The
predictive properties of our score are comparable with these
previously published scores.9,10,14 Our score has the advantage
of including DWI and can, therefore, be used in the first week
of life, a period when important clinical decisions may have
to bemade and duringwhich additional neuroprotective thera-
pies could be initiated.Another advantage of our scoring system
is that we use a point-by-point formwith clear descriptions of
what is considered moderate or severe injury, which can even
be used by less experienced MRI readers. The scoring systems
published byBarkovich et al,Rutherford et al (TOBY trial [Total
Body Hypothermia for Neonatal Encephalopathy]), and
Shankaran et al (National Institute of ChildHealth andHuman
Development [NICHD]) do not use an item-based scoring
system, but group patterns of injury together.9,10,14 In our ex-
perience, it is sometimesdifficult to score infantswhohave injury
who do not fit the categories exactly.Additionally, the NICHD
scoring system puts basal ganglia/thalamic injury and white
matter injury in the same severity grade, although they do not
have the same implications for outcome.21-24 Four previously
published scoring systems included DWI and target scans ob-
tained in the first week of life as well.4,25-27 The score presented
by Jyoti et al had good predictive value, but included only 20
infants with a follow-up time of only 12 months.25 Conclu-
sions about the predictive value of that score should therefore
be consideredwith caution.Furthermore, the Jyoti score, similar
to the NICHD score, also puts basal ganglia/thalamic injury
and white matter injury in the same severity grade. The score
presented by Cheong et al had a good specificity, but its sen-
sitivity was suboptimal (0.68).28 Cavalleri et al used the sum-
mation score presentedpreviously byBarkovich et al onDWI.14,26
This score showed a high sensitivity (1.00) but a lower speci-
ficity (0.67) and was based on ADCmeasurements, which are
more complex and time consuming. The recently published
score by Trivedi et al,whichwasweighted for greymatter injury,
had a lower area under the curve of 0.72 (95% CI, 0.57-0.86),
sensitivity of 0.77, and specificity of 0.46.27
Our results from a population of infants treated with thera-
peutic hypothermia confirm that injury to the deep grey matter
is associated with adverse outcome in general and impaired
motor function.White matter injury was not included in the
prediction model for outcome at 2 years of age, because many
infants with a high white matter subscore also had a high grey
matter subscore. Only the grey matter score was included, sug-
gesting that outcome was determined mainly by injury to the
grey matter. These results support the findings of Harteman
et al.23 We found no association between the white matter
subscore and IQ at school age, which is different from other
reports in the literature.21,29-31 However, these studies were per-
formed in normothermic infants and included infants with iso-
lated severe white matter injury. In our cohort, infants with
isolated white matter injury had only mild to moderate lesions,
which did not have a significant impact on their cognition. For
other populations, such as normothermic infants or infants
with metabolic or infectious disorders, the score can be used
to perform a complete assessment of the brain and quantify
injury. However, the predictive value of the score will be dif-
ferent and needs to be ascertained for each population sepa-
rately. Cerebellar injury was also not included in the prediction
model, even though it was related to poor outcomes in cohort
1. Again, many infants with a high cerebellum subscore also
had a high grey matter subscore, suggesting that deep grey
matter injury is more important for outcome prediction than
cerebellar injury. Besides, the majority of cerebellar injury was
a rather unspecific increased signal on T2-weighted imaging,
only 5.7% had a cerebellar hemorrhage.
We were, unfortunately, unable to assess and compare the
quality of the score in the first vs the second week of life, because
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only a limited number of MRIs were performed in the second
week of life. During the first week of life, it is best to perform
the score based on the T1- and T2-weighted images com-
bined with DWI, because DWI has been shown to be the most
reliable sequence to assess injury in HIE in the first week of
life.15 In the second week of life DWI abnormalities may no
longer be visible owing to pseudonormalization.32 The optimal
time window for performing DWI in our opinion would be
between days 4 and 7. At this point, rewarming has been com-
pleted and DWI abnormalities will have reached their full
extent,33 and pseudonormalization will not yet have oc-
curred. However, the score can also be performed in the second
week using T1- and T2-weighted images only. ADC and 1H-
MRSmeasurements (lactate and NAA) in the basal ganglia can
add significantly to the predictive properties of MRI. In con-
trast with ADC, which shows pseudonormalization after the
first week,32 1H-MRSmeasurements remain abnormal for a pro-
longed period of time.34
The limitations of our study are the lack of 1H-MRS mea-
surements in cohort 2; thus, the score including 1H-MRS mea-
surements still requires validation in another cohort.
Furthermore, not all infants had follow-up at school age, which
could have led to sampling bias. A significant difference in age
at WPPSI/WISC assessment was seen between cohorts 1 and
2; however, regression analysis (data not shown) showed no
relation between age at assessment and IQ.A difference in mor-
tality and survival with impairment was observed between
cohorts 1 and 2 as well. However, the proportion of infants
with adverse outcome, either death or impairment, was exactly
the same. In cohort 1, more infants died owing to redirec-
tion of care, but this was compensated by a higher number of
infants that survived with impairment in cohort 2. The OR
for prediction of adverse outcome was, therefore, not af-
fected and remained stable in both cohorts and when infants
who died were excluded. The MRI magnet strength was vari-
able in this study, but we do not expect this factor to have in-
fluenced our results because magnetic field strength has been
demonstrated not to affect ADC or 1H-MRS values.8 Most of
our MRIs were performed in the first week after birth, and the
predictive value of the score in the second week after birth still
needs to be assessed. The sensitivity of the grey matter subscore
was not as good in cohort 2 compared with cohort 1 (0.42 at
2 years of age and 0.50 at school age), yet the specificity, posi-
tive predictive value, negative predictive value, and accuracy
remained good (>0.84). The reduction in sensitivity might be
explained by the greater proportion of MRIs of moderate to
poor quality in the test cohort. A poor quality MRI could result
in an underestimation of the brain lesions and a lower sensi-
tivity, underlining the importance of a good quality MRI. Al-
though white matter and cerebellum injury did not have
additional predictive value in our cohort, these factors could
well be predictive in preterm infants, and other high-risk new-
borns. Scoring systems often perform quite differently in other
populations.We should, therefore, always be careful when using
scoring systems in other populations.
Ideally, the predictive value of scores and the reliability and
applicability of cutoff values should be determined for each
population separately. It is also possible that with a larger
number of subjects or another cohort with a different distri-
bution of injury, there may be a subset of HIE infants with pre-
dominant watershed/white matter patterns (without significant
basal ganglia/thalamic injury) that would relate to cognitive
outcomes. Our scoring system has some theoretical advan-
tages over other systems, but these have not been validated from
our study because we could not test other scores on our cohort,
because these scores were different in that they do not use DWI.
In summary, we developed a novel MRI score that in-
cludes DWI, assesses all relevant brain areas, and was tested
in 2 independent, international cohorts. In infants with thera-
peutic hypothermia after perinatal asphyxia, the grey matter
subscore with the presented cutoff values and predicted prob-
ability graphs may be of use in prognosticating outcome. We
also provide additional evidence that in this population
outcome is mainly determined by injury to the deep grey matter
area, independent of lesions to other areas of the brain such
as the white matter. ■
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Figure 3. Predicted probability of death or impairment A, at 2 years of age and B, at school age based on the grey matter
subscore in cohort 1.
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Table I. MRI scoring form
Items
Sequence used
to assess injury Degree
Grey matter 0 1 2
1 Thalamus abnormal SI or diffusion restriction T1/T2 DWI No Focal (<50%) Extensive (≥50%)
Specify location Unilateral Bilateral
2 Basal ganglia abnormal SI or diffusion restriction T1/T2 DWI No Focal (<50%) Extensive (≥50%)
Specify location Unilateral Bilateral
3 PLIC myelination or diffusion restriction T1/T2 DWI Normal or no
diffusion restriction
Equivocal/partially myelinated or
partial (<50%) diffusion restriction
Absent myelination or extensive
(≥50%) diffusion restriction
Specify location Unilateral Bilateral
4 Brainstem (peduncles) abnormal SI or diffusion restriction T1/T2 DWI No Focal (<50%) Extensive (≥50%)
Specify location Unilateral Bilateral
5 Perirolandic cortex diffusion restriction DWI No Mild Clear
Specify location Unilateral Bilateral
6 Hippocampus diffusion restriction DWI No Yes
Specify location Unilateral Bilateral
Grey matter subscore
Basal ganglia NAA 1H-MRS Normal Reduced
Basal ganglia lactate 1H-MRS Absent Increased
Grey matter subscore (including 1H-MRS)
White matter/cortex 0 1 2
1 Cortex abnormal SI or diffusion restriction not being perirolandic cortex T1/T2 DWI No Focal (1 lobe) Extensive (>1 lobe)
Specify location Unilateral Bilateral
2 White matter increased SI or diffusion restriction not being PWML T1/T2 DWI No Focal (1 lobe) Extensive (>1 lobe)
Specify location Unilateral Bilateral
3 PWML T1/T2, DWI, SWI No <6 ≥6
Specify location Unilateral Bilateral
4 Hemorrhage not being PWML T1/T2, SWI No Single hemorrhage <1.5 cm ≥1.5 cm or multiple hemorrhages
Specify location Unilateral Bilateral
5 Optic radiation diffusion restriction DWI No Mild Clear
Specify location Unilateral Bilateral
6 Corpus callosum diffusion restriction DWI No Yes
White matter subscore
Cerebellum 0 1 2
1 Cerebellum abnormal SI or diffusion restriction T1/T2 DWI No Focal (<0.5 cm) Extensive (≥0.5 cm or multiple lesions)
Specify location Unilateral Bilateral
2 Cerebellar hemorrhage T1/T2, SWI No Single hemorrhage <0.5 cm ≥0.5 cm or multiple hemorrhages
Specify location Unilateral Bilateral
Cerebellum subscore
Additional 0 1 2
1 IVH T1/T2, SWI No Yes
2 SDH T1/T2 No Yes
3 CSVT T1/T2, MRV No Yes
Additional subscore
Total score (grey matter + white matter + cerebellum + additional score)
CSVT, Cerebral sinovenous thrombosis; IVH, intraventricular hemorrhage; MRV, magnetic resonance venography; PLIC, posterior limb of the internal capsule; PWML, punctate white matter lesions; SDH, subdural hemorrhage; SI, signal intensity; SWI, susceptibility
weighted imaging.
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